Literature DB >> 4685084

Reduction of experimental myocardial infarct size by corticosteroid administration.

P Libby, P R Maroko, C M Bloor, B E Sobel, E Braunwald.   

Abstract

The influence of the administration of pharmacologic doses of hydrocortisone on the extent and severity of acute myocardial ischemic injury and on subsequent necrosis after acute coronary occlusion was investigated in 28 dogs. In order to study acute myocardial injury, repeated epicardial electrocardiograms were recorded from 10 to 15 sites on the anterior surface of the left ventricle. Average ST segment elevation (ST) and the number of sites in which ST segment elevation exceeded 2 mV (NST), indices of the magnitude and extent of myocardial injury, respectively, were analyzed at 30 and 60 min after coronary occlusion. In the control group ST and NST did not change significantly in this time interval while in the treated group, which received 50 mg/kg hydrocortisone just after the 30 min recording, ST fell from 3.5+/-0.8 to 1.1+/-0.4 mV (P<0.01) and NST was reduced from 6.7+/-1.1 to 1.4+/-0.8 (P<0.01). In order to study the influence of hydrocortisone on necrosis, epicardial ST segment elevation 15 min after coronary occlusion was compared to myocardial creatine phosphokinase activity (CPK) and histologic appearance 24 h later in each site. In a control group (14 dogs) a relationship was established between ST segment elevation at 15 min (in millivolts) and CPK activity (in international units per milligram of protein) 24 h later: log CPK = -0.0611ST + 1.26 (N = 102 specimens, r = -0.79). In the treated groups, hydrocortisone (50 mg/kg i.v.) was given either at 30 min after occlusion (seven dogs) or at 6 h after occlusion (six dogs). Both groups received supplementary doses of hydrocortisone (25 mg/kg) 12 h after occlusion. The two treated groups exhibited less CPK depression than that expected from ST segment elevation at each site, with slopes of the regression lines which were significantly less steep: log CPK = -0.0288ST + 1.26 (N = 48, r = -0.71) and log CPK = -0.0321ST + 1.31 (N = 48, r = -0.76) in the (1/2) h and 6 h groups, respectively. Histologically, sites with ST segment elevations of less than 2 mV at 15 min after occlusion exhibited normal appearance 24 h later. Sites with ST segment elevations (> 2 mV) in the control group showed histologic changes compatible with early myocardial infarction in 96% of specimens, while this occurred only in 61% and 63% of specimens, respectively, in the treated groups, showing that over one third of the sites were protected from undergoing necrosis due to the intervening hydrocortisone treatment. Thus pharmacological doses of hydrocortisone prevent myocardial cells from progressing to ischemic necrosis even when administration is initiated 6 h after coronary occlusion.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4685084      PMCID: PMC302298          DOI: 10.1172/JCI107221

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  44 in total

1.  A TRIAL OF HYDROCARTISONE IN ACUTE MYOCARDIAL INFARCTION.

Authors:  J L DALL; A A PEEL
Journal:  Lancet       Date:  1963-11-23       Impact factor: 79.321

2.  ULTRASTRUCTURE AUTORADIOGRAPHY AND LYSOSOME STUDIES IN MYOCARDIUM.

Authors:  M W WHEAT
Journal:  J Mt Sinai Hosp N Y       Date:  1965 Mar-Apr

3.  The effect of cortisone on experimentally produced myocardial infarcts.

Authors:  N G HEPPER; R D PRUITT; D E DONALD; J E EDWARDS
Journal:  Circulation       Date:  1955-05       Impact factor: 29.690

4.  Adams-Stokes syndrome associated with chronic heart block. Treatment with corticosteroids.

Authors:  C K FRIEDBERG; M KAHN; J SCHEUER; S BLEIFER; S DACK
Journal:  J Am Med Assoc       Date:  1960-03-12

5.  Effects of increased arterial pressure and positive inotropic agents on the severity of myocardial ischemia in the acutely depressed heart.

Authors:  T Watanabe; J W Covell; P R Maroko; E Braunwald; J Ross
Journal:  Am J Cardiol       Date:  1972-09       Impact factor: 2.778

6.  Precordial S-T segment elevation mapping: an atraumatic method for assessing alterations in the extent of myocardial ischemic injury. The effects of pharmacologic and hemodynamic interventions.

Authors:  P R Maroko; P Libby; J W Covell; B E Sobel; J Ross; E Braunwald
Journal:  Am J Cardiol       Date:  1972-02       Impact factor: 2.778

7.  Effect of glucose-insulin-potassium infusion on myocardial infarction following experimental coronary artery occlusion.

Authors:  P R Maroko; P Libby; B E Sobel; C M Bloor; H D Sybers; W E Shell; J W Covell; E Braunwald
Journal:  Circulation       Date:  1972-06       Impact factor: 29.690

8.  The hemodynamic effects of massive steroids in clinical shock.

Authors:  R F Wilson; R R Fisher
Journal:  Surg Gynecol Obstet       Date:  1968-10

9.  Quantitative study of infarcted myocardium in cardiogenic shock.

Authors:  C Harnarayan; M A Bennett; B L Pentecost; D B Brewer
Journal:  Br Heart J       Date:  1970-11

10.  The influence of diastolic augmentation on infarct size following coronary artery ligation.

Authors:  M M Nachlas; M P Siedband
Journal:  J Thorac Cardiovasc Surg       Date:  1967-05       Impact factor: 5.209

View more
  63 in total

1.  Rapid nontranscriptional activation of endothelial nitric oxide synthase mediates increased cerebral blood flow and stroke protection by corticosteroids.

Authors:  Florian P Limbourg; Zhihong Huang; Jean-Christophe Plumier; Tommaso Simoncini; Masayuki Fujioka; Jan Tuckermann; Günther Schütz; Michael A Moskowitz; James K Liao
Journal:  J Clin Invest       Date:  2002-12       Impact factor: 14.808

2.  Glucocorticoid treatment and cardiovascular disease.

Authors:  M K C Ng; D S Celermajer
Journal:  Heart       Date:  2004-08       Impact factor: 5.994

3.  Inverted T waves in patient with Addisonian crisis.

Authors:  Firat Ozcan; Ihsan Ustun; Dilek Berker; Yusuf Aydin; Tuncay Delibasi; Serdar Guler
Journal:  J Natl Med Assoc       Date:  2005-11       Impact factor: 1.798

4.  Colloidal lanthanum as a marker for impaired plasma membrane permeability in ischemic dog myocardium.

Authors:  S Hoffstein; D E Gennaro; A C Fox; J Hirsch; F Streuli; G Weissmann
Journal:  Am J Pathol       Date:  1975-05       Impact factor: 4.307

5.  Massive doses of methylprednisolone (30 mg/kg) in man: immediate haemodynamic effects in "low output state".

Authors:  S Piepenbrock; G Hempelmann; C Westermann
Journal:  Intensive Care Med       Date:  1977-08       Impact factor: 17.440

Review 6.  Anti-inflammatory therapies in myocardial infarction: failures, hopes and challenges.

Authors:  Shuaibo Huang; Nikolaos G Frangogiannis
Journal:  Br J Pharmacol       Date:  2018-03-04       Impact factor: 8.739

7.  Steroids prevent late extension of radiofrequency lesions in the thigh muscle of infant rats: implications for pediatric ablation.

Authors:  Guilherme Fenelon; Rinaldo Fernandes; Marcello Franco; Angelo A V de Paola
Journal:  J Interv Card Electrophysiol       Date:  2003-08       Impact factor: 1.900

8.  Biochemical markers for cardiovascular risk following treatment in endogenous Cushing's syndrome.

Authors:  C Kristo; T Ueland; K Godang; P Aukrust; J Bollerslev
Journal:  J Endocrinol Invest       Date:  2008-05       Impact factor: 4.256

9.  Ibuprofen inhibits granulocyte responses to inflammatory mediators. A proposed mechanism for reduction of experimental myocardial infarct size.

Authors:  P J Flynn; W K Becker; G M Vercellotti; D J Weisdorf; P R Craddock; D E Hammerschmidt; R C Lillehei; H S Jacob
Journal:  Inflammation       Date:  1984-03       Impact factor: 4.092

10.  Consumption of classical complement components by heart subcellular membranes in vitro and in patients after acute myocardial infarction.

Authors:  R N Pinckard; M S Olson; P C Giclas; R Terry; J T Boyer; R A O'Rourke
Journal:  J Clin Invest       Date:  1975-09       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.